Suppr超能文献

亚急性甲状腺炎患者对人甲状腺提取物的淋巴细胞转化反应。

Lymphocyte transformation in response to human thyroid extract in patients with subacute thyroiditis.

作者信息

Wall J R, Fang S L, Ingbar S H, Braverman L E

出版信息

J Clin Endocrinol Metab. 1976 Sep;43(3):587-90. doi: 10.1210/jcem-43-3-587.

Abstract

Seven patients with subacute thyroiditis were studied for evidence of cell-mediated immunity (CMI) to human thyroid extract, as judged from lymphocyte transformation responses, measured by the increase in labeled thymidine uptake in vitro. Significant transformation was observed in lymphocytes from five of the seven patients with active subacute thyroiditis, and in the lymphocytes from only three of 15 patients with Graves disease (x2, P EQUALS 0.036). Repeated studies of lymphocyte transformation were done in four of the patients with subacute thyroiditis, three of whom initially showed abnormal responses. By eight weeks after initial studies, when all patients were in clinical remission without treatment, transformation responses were within the normal range. Thyroid antibodies were absent or present in low titer (is less than 1:100) in sera of patients with subacute thyroiditis, and became undetectable by eight weeks in those patients initially positive. In contrast, significant titers of antithyroid antibodies were frequently present in patients with Graves' disease. The present studies have shown the occurence of CMI to thyroid antigens during the active phase of subacute thyroiditis. The abnormality was transient, however, since it disappeared when the disease had resolved. These findings strongly suggest that the release of thyroid antigen leading tothe development of a cell-mediated immune responses is not in itself sufficient to initiate chronic immunological disease of the thyroid. If, as some have suggested, Hashimoto's disease or Graves' disease are characterized by a permanent disorder of CMI, then in these diseases either the antigenic stimulus is persistent or there exists an intrinsic disorder of immune surveillance.

摘要

对7例亚急性甲状腺炎患者进行了研究,以寻找针对人甲状腺提取物的细胞介导免疫(CMI)证据,这是根据淋巴细胞转化反应来判断的,通过体外标记胸腺嘧啶核苷摄取量的增加来测量。在7例活动性亚急性甲状腺炎患者中的5例患者的淋巴细胞中观察到显著的转化,而在15例格雷夫斯病患者中只有3例患者的淋巴细胞出现显著转化(χ2,P等于0.036)。对4例亚急性甲状腺炎患者进行了淋巴细胞转化的重复研究,其中3例最初显示出异常反应。在初始研究后的8周时,所有患者未经治疗均处于临床缓解状态,此时转化反应在正常范围内。亚急性甲状腺炎患者血清中不存在甲状腺抗体或甲状腺抗体滴度较低(小于1:100),并且在那些最初呈阳性的患者中,到8周时甲状腺抗体变得无法检测到。相比之下,格雷夫斯病患者中经常存在显著滴度的抗甲状腺抗体。本研究表明在亚急性甲状腺炎的活动期存在针对甲状腺抗原的CMI。然而,这种异常是短暂的,因为当疾病消退时它就消失了。这些发现强烈表明,导致细胞介导免疫反应发生的甲状腺抗原释放本身不足以引发甲状腺的慢性免疫性疾病。如果如一些人所认为的那样,桥本氏病或格雷夫斯病的特征是CMI的永久性紊乱,那么在这些疾病中,要么抗原刺激是持续存在的,要么存在免疫监视的内在紊乱。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验